MYRIAD GENETICS, INC. Accrued Royalties, Current
MYRIAD GENETICS, INC. (MYGN) had Accrued Royalties, Current of $5.90 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedRoyaltiesCurrent · last filed 2026-07-31
- 2026-06-30: Accrued Royalties, Current $5.90M.
- 2026-03-31: Accrued Royalties, Current $4.70M.
- 2025-12-31: Accrued Royalties, Current $4.70M.
- 2025-09-30: Accrued Royalties, Current $5.60M.
| Period end | Accrued Royalties, Current |
|---|---|
| 2026-06-30 | $5.90M 10-Q · filed 2026-07-31 |
| 2026-03-31 | $4.70M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $4.70M 10-Q · filed 2026-07-31 |
| 2025-09-30 | $5.60M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $5.70M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $6.00M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $6.50M 10-K · filed 2026-02-24 |
| 2024-09-30 | $6.60M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $6.40M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $5.70M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $5.30M 10-K · filed 2025-02-28 |
| 2023-09-30 | $5.70M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $5.10M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $5.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $4.80M 10-K · filed 2024-02-28 |
| 2022-09-30 | $4.70M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $4.80M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $5.00M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $5.40M 10-K · filed 2023-03-01 |
| 2021-09-30 | $5.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.00M 10-Q · filed 2021-08-04 |
| 2020-12-31 | $3.80M 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |